A myelodysplastic syndrome, often abbreviated MDS, is one of a group of cancers in which blood cells in the bone marrow do not mature and, as a result, do not develop into healthy blood cells. Early on, no symptoms are typically seen. Later symptoms may include fatigue, shortness of breath, bleeding disorders, anemia, or frequent infections. Some types may develop into acute myeloid leukemia.
Facts
Classification
Body SystemLymphatic or Immune System 1 ICD-10 ChapterIII: Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism 1 Communicable or Non-communicable Transmission Route First DescribedThe article says the disorder went by many names until the 1976 FAB classification popularized the term MDS; 1953 is recorded as the first description as a specific entity, under the name preleukemia. Sources
1. Wikipedia: ICD-10
WikipediaList of chapters, Chapter IIIQuote, List of chapters, Chapter III
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
2. Wikipedia: Non-communicable disease
WikipediaLead section, transmission-route statement (inferred from disease-category)
NCDs include Parkinson's disease, autoimmune diseases, strokes, heart diseases, cancers, diabetes, chronic kidney disease, osteoarthritis, osteoporosis, Alzheimer's disease, cataracts, and others.
Named examples section
NCDs include Parkinson's disease, autoimmune diseases, strokes, heart diseases, cancers, diabetes, chronic kidney disease, osteoarthritis, osteoporosis, Alzheimer's disease, cataracts, and others.
View the Source 3. Myelodysplastic Syndrome (Wikipedia)
Wikimedia FoundationWikipedia: Myelodysplastic syndrome, History sectionQuote, Wikipedia: Myelodysplastic syndrome, History section
The first description of "preleukemia" as a specific entity was published in 1953 by Block et al.
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.